Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | DiseaseId | DiseaseName | DiseaseMIM | ConceptID | Source | Typical association | HGMD variants | ClinVar variants | HGNC ID | GeneMIM |
---|
HPO disease - gene - phenotype typical associations: |
HP:0000820 | HP:0000820 | Abnormality of the thyroid gland | 0 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0000820 | Abnormality of the thyroid gland | 0 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0000820 | Abnormality of the thyroid gland | 0 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0000820 | Abnormality of the thyroid gland | 0 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0000820 | Abnormality of the thyroid gland | 0 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0000820 | Abnormality of the thyroid gland | 0 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0000820 | Abnormality of the thyroid gland | 0 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0000820 | Abnormality of the thyroid gland | 0 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0000820 | Abnormality of the thyroid gland | 0 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0000820 | Abnormality of the thyroid gland | 0 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0000820 | Abnormality of the thyroid gland | 0 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0000820 | Abnormality of the thyroid gland | 0 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0000820 | Abnormality of the thyroid gland | 0 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0011772 | Abnormal thyroid morphology | 1 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0002926 | Abnormality of thyroid physiology | 1 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0011772 | Abnormal thyroid morphology | 1 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0002926 | Abnormality of thyroid physiology | 1 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0011772 | Abnormal thyroid morphology | 1 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0002926 | Abnormality of thyroid physiology | 1 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0002926 | Abnormality of thyroid physiology | 1 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0011772 | Abnormal thyroid morphology | 1 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0011772 | Abnormal thyroid morphology | 1 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0002926 | Abnormality of thyroid physiology | 1 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0011772 | Abnormal thyroid morphology | 1 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0002926 | Abnormality of thyroid physiology | 1 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0011772 | Abnormal thyroid morphology | 1 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0002926 | Abnormality of thyroid physiology | 1 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0011772 | Abnormal thyroid morphology | 1 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0002926 | Abnormality of thyroid physiology | 1 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0011772 | Abnormal thyroid morphology | 1 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0002926 | Abnormality of thyroid physiology | 1 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0011772 | Abnormal thyroid morphology | 1 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0002926 | Abnormality of thyroid physiology | 1 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0002926 | Abnormality of thyroid physiology | 1 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0011772 | Abnormal thyroid morphology | 1 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0011772 | Abnormal thyroid morphology | 1 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0002926 | Abnormality of thyroid physiology | 1 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0011772 | Abnormal thyroid morphology | 1 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0002926 | Abnormality of thyroid physiology | 1 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0002930 | Impaired sensitivity to thyroid hormone | 2 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0025482 | Positive perchlorate discharge test | 2 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0100031 | Neoplasm of the thyroid gland | 2 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0008229 | Thyroid lymphangiectasia | 2 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0008247 | Euthyroid hyperthyroxinemia | 2 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0000821 | Hypothyroidism | 2 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0008249 | Thyroid hyperplasia | 2 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0100646 | Thyroiditis | 2 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0008188 | Thyroid dysgenesis | 2 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0025388 | Thyroid nodule | 2 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0031221 | Abnormal radioactive iodine uptake test result | 2 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0010518 | Thyroglossal cyst | 2 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0011789 | Impaired sensitivity to thyroid stimulating hormone | 2 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0008263 | Thyroid defect in oxidation and organification of iodide | 2 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0033079 | Aplasia/Hypoplasia of the thyroid gland | 2 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0031508 | Abnormal thyroid hormone level | 2 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0033080 | Abnormal TSH response to thyrotrophin-releasing hormone stimulation test | 2 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0000853 | Goiter | 2 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0000836 | Hyperthyroidism | 2 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0008229 | Thyroid lymphangiectasia | 2 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0008247 | Euthyroid hyperthyroxinemia | 2 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0100031 | Neoplasm of the thyroid gland | 2 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0000821 | Hypothyroidism | 2 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0100646 | Thyroiditis | 2 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0008188 | Thyroid dysgenesis | 2 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0008249 | Thyroid hyperplasia | 2 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0031221 | Abnormal radioactive iodine uptake test result | 2 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0011789 | Impaired sensitivity to thyroid stimulating hormone | 2 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0008263 | Thyroid defect in oxidation and organification of iodide | 2 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0010518 | Thyroglossal cyst | 2 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0025388 | Thyroid nodule | 2 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0033079 | Aplasia/Hypoplasia of the thyroid gland | 2 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0002930 | Impaired sensitivity to thyroid hormone | 2 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0031508 | Abnormal thyroid hormone level | 2 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0033080 | Abnormal TSH response to thyrotrophin-releasing hormone stimulation test | 2 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0000853 | Goiter | 2 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0025482 | Positive perchlorate discharge test | 2 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0000836 | Hyperthyroidism | 2 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0100031 | Neoplasm of the thyroid gland | 2 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0000821 | Hypothyroidism | 2 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0008229 | Thyroid lymphangiectasia | 2 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0008247 | Euthyroid hyperthyroxinemia | 2 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0008249 | Thyroid hyperplasia | 2 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0100646 | Thyroiditis | 2 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0008188 | Thyroid dysgenesis | 2 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0025388 | Thyroid nodule | 2 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0031221 | Abnormal radioactive iodine uptake test result | 2 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0011789 | Impaired sensitivity to thyroid stimulating hormone | 2 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0008263 | Thyroid defect in oxidation and organification of iodide | 2 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0010518 | Thyroglossal cyst | 2 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0033079 | Aplasia/Hypoplasia of the thyroid gland | 2 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0002930 | Impaired sensitivity to thyroid hormone | 2 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0031508 | Abnormal thyroid hormone level | 2 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0033080 | Abnormal TSH response to thyrotrophin-releasing hormone stimulation test | 2 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0000853 | Goiter | 2 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0025482 | Positive perchlorate discharge test | 2 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0000836 | Hyperthyroidism | 2 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0031508 | Abnormal thyroid hormone level | 2 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0033080 | Abnormal TSH response to thyrotrophin-releasing hormone stimulation test | 2 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0000853 | Goiter | 2 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0025482 | Positive perchlorate discharge test | 2 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0000836 | Hyperthyroidism | 2 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0033079 | Aplasia/Hypoplasia of the thyroid gland | 2 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0002930 | Impaired sensitivity to thyroid hormone | 2 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0008247 | Euthyroid hyperthyroxinemia | 2 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0100031 | Neoplasm of the thyroid gland | 2 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0000821 | Hypothyroidism | 2 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0008229 | Thyroid lymphangiectasia | 2 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0008188 | Thyroid dysgenesis | 2 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0008249 | Thyroid hyperplasia | 2 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0100646 | Thyroiditis | 2 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0008263 | Thyroid defect in oxidation and organification of iodide | 2 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0010518 | Thyroglossal cyst | 2 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0025388 | Thyroid nodule | 2 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0031221 | Abnormal radioactive iodine uptake test result | 2 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0011789 | Impaired sensitivity to thyroid stimulating hormone | 2 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0008247 | Euthyroid hyperthyroxinemia | 2 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0100031 | Neoplasm of the thyroid gland | 2 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0000821 | Hypothyroidism | 2 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0008229 | Thyroid lymphangiectasia | 2 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0008188 | Thyroid dysgenesis | 2 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0008249 | Thyroid hyperplasia | 2 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0100646 | Thyroiditis | 2 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0008263 | Thyroid defect in oxidation and organification of iodide | 2 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0011789 | Impaired sensitivity to thyroid stimulating hormone | 2 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0010518 | Thyroglossal cyst | 2 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0025388 | Thyroid nodule | 2 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0031221 | Abnormal radioactive iodine uptake test result | 2 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0025482 | Positive perchlorate discharge test | 2 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0002930 | Impaired sensitivity to thyroid hormone | 2 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0000853 | Goiter | 2 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0000836 | Hyperthyroidism | 2 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0033079 | Aplasia/Hypoplasia of the thyroid gland | 2 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0031508 | Abnormal thyroid hormone level | 2 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0033080 | Abnormal TSH response to thyrotrophin-releasing hormone stimulation test | 2 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0000821 | Hypothyroidism | 2 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0008229 | Thyroid lymphangiectasia | 2 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0008247 | Euthyroid hyperthyroxinemia | 2 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0100031 | Neoplasm of the thyroid gland | 2 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0100646 | Thyroiditis | 2 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0008188 | Thyroid dysgenesis | 2 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0008249 | Thyroid hyperplasia | 2 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0025388 | Thyroid nodule | 2 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0031221 | Abnormal radioactive iodine uptake test result | 2 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0011789 | Impaired sensitivity to thyroid stimulating hormone | 2 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0008263 | Thyroid defect in oxidation and organification of iodide | 2 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0010518 | Thyroglossal cyst | 2 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0033079 | Aplasia/Hypoplasia of the thyroid gland | 2 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0002930 | Impaired sensitivity to thyroid hormone | 2 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0031508 | Abnormal thyroid hormone level | 2 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0033080 | Abnormal TSH response to thyrotrophin-releasing hormone stimulation test | 2 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0000853 | Goiter | 2 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0025482 | Positive perchlorate discharge test | 2 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0000836 | Hyperthyroidism | 2 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0008229 | Thyroid lymphangiectasia | 2 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0008247 | Euthyroid hyperthyroxinemia | 2 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0100031 | Neoplasm of the thyroid gland | 2 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0000821 | Hypothyroidism | 2 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0008188 | Thyroid dysgenesis | 2 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0008249 | Thyroid hyperplasia | 2 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0100646 | Thyroiditis | 2 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0031221 | Abnormal radioactive iodine uptake test result | 2 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0011789 | Impaired sensitivity to thyroid stimulating hormone | 2 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0008263 | Thyroid defect in oxidation and organification of iodide | 2 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0010518 | Thyroglossal cyst | 2 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0025388 | Thyroid nodule | 2 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0033079 | Aplasia/Hypoplasia of the thyroid gland | 2 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0002930 | Impaired sensitivity to thyroid hormone | 2 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0031508 | Abnormal thyroid hormone level | 2 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0033080 | Abnormal TSH response to thyrotrophin-releasing hormone stimulation test | 2 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0000853 | Goiter | 2 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0025482 | Positive perchlorate discharge test | 2 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0000836 | Hyperthyroidism | 2 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0000821 | Hypothyroidism | 2 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0008229 | Thyroid lymphangiectasia | 2 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0008247 | Euthyroid hyperthyroxinemia | 2 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0100031 | Neoplasm of the thyroid gland | 2 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0100646 | Thyroiditis | 2 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0008188 | Thyroid dysgenesis | 2 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0008249 | Thyroid hyperplasia | 2 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0025388 | Thyroid nodule | 2 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0031221 | Abnormal radioactive iodine uptake test result | 2 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0011789 | Impaired sensitivity to thyroid stimulating hormone | 2 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0008263 | Thyroid defect in oxidation and organification of iodide | 2 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0010518 | Thyroglossal cyst | 2 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0033079 | Aplasia/Hypoplasia of the thyroid gland | 2 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0002930 | Impaired sensitivity to thyroid hormone | 2 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0031508 | Abnormal thyroid hormone level | 2 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0033080 | Abnormal TSH response to thyrotrophin-releasing hormone stimulation test | 2 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0000853 | Goiter | 2 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0025482 | Positive perchlorate discharge test | 2 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0000836 | Hyperthyroidism | 2 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0100031 | Neoplasm of the thyroid gland | 2 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0000821 | Hypothyroidism | 2 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0008229 | Thyroid lymphangiectasia | 2 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0008247 | Euthyroid hyperthyroxinemia | 2 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0008188 | Thyroid dysgenesis | 2 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0008249 | Thyroid hyperplasia | 2 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0100646 | Thyroiditis | 2 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0025388 | Thyroid nodule | 2 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0031221 | Abnormal radioactive iodine uptake test result | 2 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0011789 | Impaired sensitivity to thyroid stimulating hormone | 2 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0008263 | Thyroid defect in oxidation and organification of iodide | 2 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0010518 | Thyroglossal cyst | 2 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0033079 | Aplasia/Hypoplasia of the thyroid gland | 2 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0002930 | Impaired sensitivity to thyroid hormone | 2 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0031508 | Abnormal thyroid hormone level | 2 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0033080 | Abnormal TSH response to thyrotrophin-releasing hormone stimulation test | 2 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0000853 | Goiter | 2 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0025482 | Positive perchlorate discharge test | 2 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0000836 | Hyperthyroidism | 2 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0100031 | Neoplasm of the thyroid gland | 2 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0000821 | Hypothyroidism | 2 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0008229 | Thyroid lymphangiectasia | 2 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0008247 | Euthyroid hyperthyroxinemia | 2 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0008188 | Thyroid dysgenesis | 2 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0008249 | Thyroid hyperplasia | 2 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0100646 | Thyroiditis | 2 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0010518 | Thyroglossal cyst | 2 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0025388 | Thyroid nodule | 2 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0031221 | Abnormal radioactive iodine uptake test result | 2 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0011789 | Impaired sensitivity to thyroid stimulating hormone | 2 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0008263 | Thyroid defect in oxidation and organification of iodide | 2 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0000836 | Hyperthyroidism | 2 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0033079 | Aplasia/Hypoplasia of the thyroid gland | 2 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0002930 | Impaired sensitivity to thyroid hormone | 2 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0031508 | Abnormal thyroid hormone level | 2 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0033080 | Abnormal TSH response to thyrotrophin-releasing hormone stimulation test | 2 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0000853 | Goiter | 2 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0025482 | Positive perchlorate discharge test | 2 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0033079 | Aplasia/Hypoplasia of the thyroid gland | 2 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0002930 | Impaired sensitivity to thyroid hormone | 2 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0031508 | Abnormal thyroid hormone level | 2 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0033080 | Abnormal TSH response to thyrotrophin-releasing hormone stimulation test | 2 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0000853 | Goiter | 2 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0025482 | Positive perchlorate discharge test | 2 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0000836 | Hyperthyroidism | 2 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0100031 | Neoplasm of the thyroid gland | 2 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0000821 | Hypothyroidism | 2 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0008229 | Thyroid lymphangiectasia | 2 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0008247 | Euthyroid hyperthyroxinemia | 2 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0008249 | Thyroid hyperplasia | 2 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0100646 | Thyroiditis | 2 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0008188 | Thyroid dysgenesis | 2 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0025388 | Thyroid nodule | 2 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0031221 | Abnormal radioactive iodine uptake test result | 2 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0011789 | Impaired sensitivity to thyroid stimulating hormone | 2 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0008263 | Thyroid defect in oxidation and organification of iodide | 2 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0010518 | Thyroglossal cyst | 2 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0008229 | Thyroid lymphangiectasia | 2 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0008247 | Euthyroid hyperthyroxinemia | 2 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0100031 | Neoplasm of the thyroid gland | 2 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0000821 | Hypothyroidism | 2 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0008188 | Thyroid dysgenesis | 2 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0008249 | Thyroid hyperplasia | 2 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0100646 | Thyroiditis | 2 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0011789 | Impaired sensitivity to thyroid stimulating hormone | 2 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0008263 | Thyroid defect in oxidation and organification of iodide | 2 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0010518 | Thyroglossal cyst | 2 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0025388 | Thyroid nodule | 2 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0031221 | Abnormal radioactive iodine uptake test result | 2 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0031508 | Abnormal thyroid hormone level | 2 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0033080 | Abnormal TSH response to thyrotrophin-releasing hormone stimulation test | 2 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0000853 | Goiter | 2 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0025482 | Positive perchlorate discharge test | 2 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0000836 | Hyperthyroidism | 2 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0033079 | Aplasia/Hypoplasia of the thyroid gland | 2 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0002930 | Impaired sensitivity to thyroid hormone | 2 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0000821 | Hypothyroidism | 2 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0008229 | Thyroid lymphangiectasia | 2 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0008247 | Euthyroid hyperthyroxinemia | 2 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0100031 | Neoplasm of the thyroid gland | 2 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0100646 | Thyroiditis | 2 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0008188 | Thyroid dysgenesis | 2 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0008249 | Thyroid hyperplasia | 2 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0025388 | Thyroid nodule | 2 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0031221 | Abnormal radioactive iodine uptake test result | 2 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0011789 | Impaired sensitivity to thyroid stimulating hormone | 2 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0008263 | Thyroid defect in oxidation and organification of iodide | 2 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0010518 | Thyroglossal cyst | 2 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0033079 | Aplasia/Hypoplasia of the thyroid gland | 2 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0002930 | Impaired sensitivity to thyroid hormone | 2 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0031508 | Abnormal thyroid hormone level | 2 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0033080 | Abnormal TSH response to thyrotrophin-releasing hormone stimulation test | 2 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0000853 | Goiter | 2 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0025482 | Positive perchlorate discharge test | 2 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0000836 | Hyperthyroidism | 2 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0011787 | Central hypothyroidism | 3 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0100028 | Ectopic thyroid | 3 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0031505 | Abnormal circulating T4 level | 3 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0011784 | Thyrotoxicosis with diffuse goiter | 3 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0011781 | Thyroid C cell hyperplasia | 3 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0000872 | Hashimoto thyroiditis | 3 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0002890 | Thyroid carcinoma | 3 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0031219 | Reduced radioactive iodine uptake | 3 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0005990 | Thyroid hypoplasia | 3 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0000832 | Primary hypothyroidism | 3 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0011791 | Inactivating thyroid-stimulating hormone receptor defect | 3 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0011783 | Thyrotoxicosis from ectopic thyroid tissue | 3 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0012558 | Abnormal T3/T4 ratio | 3 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0031220 | Increased radioactive iodine uptake | 3 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0011780 | Thyroid hemiagenesis | 3 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0033082 | Reduced TSH response to thyrotrophin-releasing hormone stimulation test | 3 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0009798 | Euthyroid goiter | 3 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0011786 | Thyrotoxicosis with toxic single thyroid nodule | 3 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0000851 | Congenital hypothyroidism | 3 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0011790 | Activating thyroid-stimulating hormone receptor defect | 3 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0008191 | Thyroid agenesis | 3 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0032209 | Abnormal circulating free T3 level | 3 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0033081 | Absent TSH response to thyrotrophin-releasing hormone stimulation test | 3 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0008251 | Congenital goiter | 3 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0011782 | Thyroid crisis | 3 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0011785 | Thyrotoxicosis with toxic multinodular goiter | 3 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0008223 | Compensated hypothyroidism | 3 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0005994 | Nodular goiter | 3 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0000854 | Thyroid adenoma | 3 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0008225 | Thyroid follicular hyperplasia | 3 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0033076 | Abnormal circulating free T4 level | 3 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0000872 | Hashimoto thyroiditis | 3 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0000832 | Primary hypothyroidism | 3 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0002890 | Thyroid carcinoma | 3 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0031219 | Reduced radioactive iodine uptake | 3 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0005990 | Thyroid hypoplasia | 3 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0011791 | Inactivating thyroid-stimulating hormone receptor defect | 3 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0100028 | Ectopic thyroid | 3 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0031505 | Abnormal circulating T4 level | 3 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0011784 | Thyrotoxicosis with diffuse goiter | 3 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0011781 | Thyroid C cell hyperplasia | 3 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0000851 | Congenital hypothyroidism | 3 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0031220 | Increased radioactive iodine uptake | 3 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0011780 | Thyroid hemiagenesis | 3 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0011790 | Activating thyroid-stimulating hormone receptor defect | 3 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0033082 | Reduced TSH response to thyrotrophin-releasing hormone stimulation test | 3 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0009798 | Euthyroid goiter | 3 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0011783 | Thyrotoxicosis from ectopic thyroid tissue | 3 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0012558 | Abnormal T3/T4 ratio | 3 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0011786 | Thyrotoxicosis with toxic single thyroid nodule | 3 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0008223 | Compensated hypothyroidism | 3 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0008191 | Thyroid agenesis | 3 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0032209 | Abnormal circulating free T3 level | 3 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0033081 | Absent TSH response to thyrotrophin-releasing hormone stimulation test | 3 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0008251 | Congenital goiter | 3 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0011782 | Thyroid crisis | 3 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0011785 | Thyrotoxicosis with toxic multinodular goiter | 3 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0011787 | Central hypothyroidism | 3 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0033076 | Abnormal circulating free T4 level | 3 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0005994 | Nodular goiter | 3 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0000854 | Thyroid adenoma | 3 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0008225 | Thyroid follicular hyperplasia | 3 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0031505 | Abnormal circulating T4 level | 3 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0011784 | Thyrotoxicosis with diffuse goiter | 3 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0011781 | Thyroid C cell hyperplasia | 3 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0000872 | Hashimoto thyroiditis | 3 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0000832 | Primary hypothyroidism | 3 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0002890 | Thyroid carcinoma | 3 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0031219 | Reduced radioactive iodine uptake | 3 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0005990 | Thyroid hypoplasia | 3 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0011791 | Inactivating thyroid-stimulating hormone receptor defect | 3 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0100028 | Ectopic thyroid | 3 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0012558 | Abnormal T3/T4 ratio | 3 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0011786 | Thyrotoxicosis with toxic single thyroid nodule | 3 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0000851 | Congenital hypothyroidism | 3 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0031220 | Increased radioactive iodine uptake | 3 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0011780 | Thyroid hemiagenesis | 3 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0011790 | Activating thyroid-stimulating hormone receptor defect | 3 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0033082 | Reduced TSH response to thyrotrophin-releasing hormone stimulation test | 3 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0009798 | Euthyroid goiter | 3 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0011783 | Thyrotoxicosis from ectopic thyroid tissue | 3 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0011785 | Thyrotoxicosis with toxic multinodular goiter | 3 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0008223 | Compensated hypothyroidism | 3 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0008191 | Thyroid agenesis | 3 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0032209 | Abnormal circulating free T3 level | 3 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0033081 | Absent TSH response to thyrotrophin-releasing hormone stimulation test | 3 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0008251 | Congenital goiter | 3 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0011782 | Thyroid crisis | 3 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0000854 | Thyroid adenoma | 3 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0008225 | Thyroid follicular hyperplasia | 3 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0011787 | Central hypothyroidism | 3 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0033076 | Abnormal circulating free T4 level | 3 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0005994 | Nodular goiter | 3 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0033076 | Abnormal circulating free T4 level | 3 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0005994 | Nodular goiter | 3 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0000854 | Thyroid adenoma | 3 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0008225 | Thyroid follicular hyperplasia | 3 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0011787 | Central hypothyroidism | 3 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0005990 | Thyroid hypoplasia | 3 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0011791 | Inactivating thyroid-stimulating hormone receptor defect | 3 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0100028 | Ectopic thyroid | 3 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0031505 | Abnormal circulating T4 level | 3 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0011784 | Thyrotoxicosis with diffuse goiter | 3 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0011781 | Thyroid C cell hyperplasia | 3 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0000872 | Hashimoto thyroiditis | 3 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0000832 | Primary hypothyroidism | 3 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0002890 | Thyroid carcinoma | 3 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0031219 | Reduced radioactive iodine uptake | 3 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0033082 | Reduced TSH response to thyrotrophin-releasing hormone stimulation test | 3 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0009798 | Euthyroid goiter | 3 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0011783 | Thyrotoxicosis from ectopic thyroid tissue | 3 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0012558 | Abnormal T3/T4 ratio | 3 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0011786 | Thyrotoxicosis with toxic single thyroid nodule | 3 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0000851 | Congenital hypothyroidism | 3 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0031220 | Increased radioactive iodine uptake | 3 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0011780 | Thyroid hemiagenesis | 3 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0011790 | Activating thyroid-stimulating hormone receptor defect | 3 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0032209 | Abnormal circulating free T3 level | 3 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0033081 | Absent TSH response to thyrotrophin-releasing hormone stimulation test | 3 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0008251 | Congenital goiter | 3 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0011782 | Thyroid crisis | 3 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0011785 | Thyrotoxicosis with toxic multinodular goiter | 3 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0008223 | Compensated hypothyroidism | 3 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0008191 | Thyroid agenesis | 3 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0011791 | Inactivating thyroid-stimulating hormone receptor defect | 3 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0100028 | Ectopic thyroid | 3 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0031505 | Abnormal circulating T4 level | 3 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0011784 | Thyrotoxicosis with diffuse goiter | 3 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0011781 | Thyroid C cell hyperplasia | 3 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0000872 | Hashimoto thyroiditis | 3 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0000832 | Primary hypothyroidism | 3 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0002890 | Thyroid carcinoma | 3 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0031219 | Reduced radioactive iodine uptake | 3 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0005990 | Thyroid hypoplasia | 3 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0011790 | Activating thyroid-stimulating hormone receptor defect | 3 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0033082 | Reduced TSH response to thyrotrophin-releasing hormone stimulation test | 3 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0009798 | Euthyroid goiter | 3 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0011783 | Thyrotoxicosis from ectopic thyroid tissue | 3 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0012558 | Abnormal T3/T4 ratio | 3 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0011786 | Thyrotoxicosis with toxic single thyroid nodule | 3 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0000851 | Congenital hypothyroidism | 3 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0031220 | Increased radioactive iodine uptake | 3 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0011780 | Thyroid hemiagenesis | 3 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0032209 | Abnormal circulating free T3 level | 3 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0033081 | Absent TSH response to thyrotrophin-releasing hormone stimulation test | 3 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0008251 | Congenital goiter | 3 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0011782 | Thyroid crisis | 3 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0011785 | Thyrotoxicosis with toxic multinodular goiter | 3 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0008223 | Compensated hypothyroidism | 3 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0008191 | Thyroid agenesis | 3 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0033076 | Abnormal circulating free T4 level | 3 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0005994 | Nodular goiter | 3 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0000854 | Thyroid adenoma | 3 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0008225 | Thyroid follicular hyperplasia | 3 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0011787 | Central hypothyroidism | 3 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0000872 | Hashimoto thyroiditis | 3 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0000832 | Primary hypothyroidism | 3 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0002890 | Thyroid carcinoma | 3 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0031219 | Reduced radioactive iodine uptake | 3 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0005990 | Thyroid hypoplasia | 3 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0011791 | Inactivating thyroid-stimulating hormone receptor defect | 3 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0100028 | Ectopic thyroid | 3 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0031505 | Abnormal circulating T4 level | 3 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0011784 | Thyrotoxicosis with diffuse goiter | 3 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0011781 | Thyroid C cell hyperplasia | 3 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0012558 | Abnormal T3/T4 ratio | 3 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0011786 | Thyrotoxicosis with toxic single thyroid nodule | 3 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0000851 | Congenital hypothyroidism | 3 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0031220 | Increased radioactive iodine uptake | 3 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0011780 | Thyroid hemiagenesis | 3 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0011790 | Activating thyroid-stimulating hormone receptor defect | 3 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0033082 | Reduced TSH response to thyrotrophin-releasing hormone stimulation test | 3 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0009798 | Euthyroid goiter | 3 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0011783 | Thyrotoxicosis from ectopic thyroid tissue | 3 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0008223 | Compensated hypothyroidism | 3 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0008191 | Thyroid agenesis | 3 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0032209 | Abnormal circulating free T3 level | 3 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0033081 | Absent TSH response to thyrotrophin-releasing hormone stimulation test | 3 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0008251 | Congenital goiter | 3 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0011782 | Thyroid crisis | 3 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0011785 | Thyrotoxicosis with toxic multinodular goiter | 3 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0008225 | Thyroid follicular hyperplasia | 3 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0011787 | Central hypothyroidism | 3 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0033076 | Abnormal circulating free T4 level | 3 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0005994 | Nodular goiter | 3 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0000854 | Thyroid adenoma | 3 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0000832 | Primary hypothyroidism | 3 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0002890 | Thyroid carcinoma | 3 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0031219 | Reduced radioactive iodine uptake | 3 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0005990 | Thyroid hypoplasia | 3 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0011791 | Inactivating thyroid-stimulating hormone receptor defect | 3 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0100028 | Ectopic thyroid | 3 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0031505 | Abnormal circulating T4 level | 3 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0011784 | Thyrotoxicosis with diffuse goiter | 3 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0011781 | Thyroid C cell hyperplasia | 3 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0000872 | Hashimoto thyroiditis | 3 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0031220 | Increased radioactive iodine uptake | 3 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0011780 | Thyroid hemiagenesis | 3 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0011790 | Activating thyroid-stimulating hormone receptor defect | 3 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0033082 | Reduced TSH response to thyrotrophin-releasing hormone stimulation test | 3 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0009798 | Euthyroid goiter | 3 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0011783 | Thyrotoxicosis from ectopic thyroid tissue | 3 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0012558 | Abnormal T3/T4 ratio | 3 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0011786 | Thyrotoxicosis with toxic single thyroid nodule | 3 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0000851 | Congenital hypothyroidism | 3 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0008191 | Thyroid agenesis | 3 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0032209 | Abnormal circulating free T3 level | 3 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0033081 | Absent TSH response to thyrotrophin-releasing hormone stimulation test | 3 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0008251 | Congenital goiter | 3 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0011782 | Thyroid crisis | 3 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0011785 | Thyrotoxicosis with toxic multinodular goiter | 3 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0008223 | Compensated hypothyroidism | 3 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0033076 | Abnormal circulating free T4 level | 3 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0005994 | Nodular goiter | 3 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0000854 | Thyroid adenoma | 3 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0008225 | Thyroid follicular hyperplasia | 3 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0011787 | Central hypothyroidism | 3 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0011781 | Thyroid C cell hyperplasia | 3 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0000872 | Hashimoto thyroiditis | 3 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0000832 | Primary hypothyroidism | 3 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0002890 | Thyroid carcinoma | 3 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0031219 | Reduced radioactive iodine uptake | 3 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0005990 | Thyroid hypoplasia | 3 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0011791 | Inactivating thyroid-stimulating hormone receptor defect | 3 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0100028 | Ectopic thyroid | 3 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0031505 | Abnormal circulating T4 level | 3 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0011784 | Thyrotoxicosis with diffuse goiter | 3 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0012558 | Abnormal T3/T4 ratio | 3 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0011786 | Thyrotoxicosis with toxic single thyroid nodule | 3 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0000851 | Congenital hypothyroidism | 3 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0031220 | Increased radioactive iodine uptake | 3 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0011780 | Thyroid hemiagenesis | 3 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0011790 | Activating thyroid-stimulating hormone receptor defect | 3 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0033082 | Reduced TSH response to thyrotrophin-releasing hormone stimulation test | 3 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0009798 | Euthyroid goiter | 3 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0011783 | Thyrotoxicosis from ectopic thyroid tissue | 3 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0011785 | Thyrotoxicosis with toxic multinodular goiter | 3 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0008223 | Compensated hypothyroidism | 3 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0008191 | Thyroid agenesis | 3 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0032209 | Abnormal circulating free T3 level | 3 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0033081 | Absent TSH response to thyrotrophin-releasing hormone stimulation test | 3 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0008251 | Congenital goiter | 3 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0011782 | Thyroid crisis | 3 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0000854 | Thyroid adenoma | 3 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0008225 | Thyroid follicular hyperplasia | 3 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0011787 | Central hypothyroidism | 3 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0033076 | Abnormal circulating free T4 level | 3 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0005994 | Nodular goiter | 3 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0100028 | Ectopic thyroid | 3 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0031505 | Abnormal circulating T4 level | 3 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0011784 | Thyrotoxicosis with diffuse goiter | 3 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0011781 | Thyroid C cell hyperplasia | 3 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0000872 | Hashimoto thyroiditis | 3 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0000832 | Primary hypothyroidism | 3 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0002890 | Thyroid carcinoma | 3 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0031219 | Reduced radioactive iodine uptake | 3 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0005990 | Thyroid hypoplasia | 3 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0011791 | Inactivating thyroid-stimulating hormone receptor defect | 3 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0011783 | Thyrotoxicosis from ectopic thyroid tissue | 3 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0012558 | Abnormal T3/T4 ratio | 3 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0011786 | Thyrotoxicosis with toxic single thyroid nodule | 3 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0000851 | Congenital hypothyroidism | 3 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0031220 | Increased radioactive iodine uptake | 3 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0011780 | Thyroid hemiagenesis | 3 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0011790 | Activating thyroid-stimulating hormone receptor defect | 3 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0033082 | Reduced TSH response to thyrotrophin-releasing hormone stimulation test | 3 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0009798 | Euthyroid goiter | 3 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0011782 | Thyroid crisis | 3 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0011785 | Thyrotoxicosis with toxic multinodular goiter | 3 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0008223 | Compensated hypothyroidism | 3 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0008191 | Thyroid agenesis | 3 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0032209 | Abnormal circulating free T3 level | 3 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0033081 | Absent TSH response to thyrotrophin-releasing hormone stimulation test | 3 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0008251 | Congenital goiter | 3 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0005994 | Nodular goiter | 3 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0000854 | Thyroid adenoma | 3 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0008225 | Thyroid follicular hyperplasia | 3 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0011787 | Central hypothyroidism | 3 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0033076 | Abnormal circulating free T4 level | 3 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0100028 | Ectopic thyroid | 3 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0031505 | Abnormal circulating T4 level | 3 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0011784 | Thyrotoxicosis with diffuse goiter | 3 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0011781 | Thyroid C cell hyperplasia | 3 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0000872 | Hashimoto thyroiditis | 3 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0000832 | Primary hypothyroidism | 3 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0002890 | Thyroid carcinoma | 3 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0031219 | Reduced radioactive iodine uptake | 3 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0005990 | Thyroid hypoplasia | 3 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0011791 | Inactivating thyroid-stimulating hormone receptor defect | 3 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0009798 | Euthyroid goiter | 3 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0011783 | Thyrotoxicosis from ectopic thyroid tissue | 3 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0012558 | Abnormal T3/T4 ratio | 3 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0011786 | Thyrotoxicosis with toxic single thyroid nodule | 3 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0000851 | Congenital hypothyroidism | 3 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0031220 | Increased radioactive iodine uptake | 3 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0011780 | Thyroid hemiagenesis | 3 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0011790 | Activating thyroid-stimulating hormone receptor defect | 3 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0033082 | Reduced TSH response to thyrotrophin-releasing hormone stimulation test | 3 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0011782 | Thyroid crisis | 3 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0011785 | Thyrotoxicosis with toxic multinodular goiter | 3 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0008223 | Compensated hypothyroidism | 3 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0008191 | Thyroid agenesis | 3 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0032209 | Abnormal circulating free T3 level | 3 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0033081 | Absent TSH response to thyrotrophin-releasing hormone stimulation test | 3 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0008251 | Congenital goiter | 3 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0033076 | Abnormal circulating free T4 level | 3 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0005994 | Nodular goiter | 3 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0000854 | Thyroid adenoma | 3 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0008225 | Thyroid follicular hyperplasia | 3 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0011787 | Central hypothyroidism | 3 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0000854 | Thyroid adenoma | 3 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0008225 | Thyroid follicular hyperplasia | 3 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0011787 | Central hypothyroidism | 3 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0033076 | Abnormal circulating free T4 level | 3 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0005994 | Nodular goiter | 3 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0011781 | Thyroid C cell hyperplasia | 3 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0000872 | Hashimoto thyroiditis | 3 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0000832 | Primary hypothyroidism | 3 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0002890 | Thyroid carcinoma | 3 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0031219 | Reduced radioactive iodine uptake | 3 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0005990 | Thyroid hypoplasia | 3 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0011791 | Inactivating thyroid-stimulating hormone receptor defect | 3 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0100028 | Ectopic thyroid | 3 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0031505 | Abnormal circulating T4 level | 3 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0011784 | Thyrotoxicosis with diffuse goiter | 3 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0012558 | Abnormal T3/T4 ratio | 3 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0011786 | Thyrotoxicosis with toxic single thyroid nodule | 3 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0000851 | Congenital hypothyroidism | 3 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0031220 | Increased radioactive iodine uptake | 3 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0011780 | Thyroid hemiagenesis | 3 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0011790 | Activating thyroid-stimulating hormone receptor defect | 3 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0033082 | Reduced TSH response to thyrotrophin-releasing hormone stimulation test | 3 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0009798 | Euthyroid goiter | 3 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0011783 | Thyrotoxicosis from ectopic thyroid tissue | 3 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0011785 | Thyrotoxicosis with toxic multinodular goiter | 3 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0008223 | Compensated hypothyroidism | 3 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0008191 | Thyroid agenesis | 3 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0032209 | Abnormal circulating free T3 level | 3 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0033081 | Absent TSH response to thyrotrophin-releasing hormone stimulation test | 3 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0008251 | Congenital goiter | 3 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0011782 | Thyroid crisis | 3 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0002890 | Thyroid carcinoma | 3 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0031219 | Reduced radioactive iodine uptake | 3 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0005990 | Thyroid hypoplasia | 3 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0011791 | Inactivating thyroid-stimulating hormone receptor defect | 3 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0100028 | Ectopic thyroid | 3 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0031505 | Abnormal circulating T4 level | 3 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0011784 | Thyrotoxicosis with diffuse goiter | 3 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0011781 | Thyroid C cell hyperplasia | 3 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0000872 | Hashimoto thyroiditis | 3 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0000832 | Primary hypothyroidism | 3 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0031220 | Increased radioactive iodine uptake | 3 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0011780 | Thyroid hemiagenesis | 3 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0011790 | Activating thyroid-stimulating hormone receptor defect | 3 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0033082 | Reduced TSH response to thyrotrophin-releasing hormone stimulation test | 3 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0009798 | Euthyroid goiter | 3 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0011783 | Thyrotoxicosis from ectopic thyroid tissue | 3 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0012558 | Abnormal T3/T4 ratio | 3 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0011786 | Thyrotoxicosis with toxic single thyroid nodule | 3 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0000851 | Congenital hypothyroidism | 3 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0008191 | Thyroid agenesis | 3 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0032209 | Abnormal circulating free T3 level | 3 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0033081 | Absent TSH response to thyrotrophin-releasing hormone stimulation test | 3 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0008251 | Congenital goiter | 3 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0011782 | Thyroid crisis | 3 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0011785 | Thyrotoxicosis with toxic multinodular goiter | 3 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0008223 | Compensated hypothyroidism | 3 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0033076 | Abnormal circulating free T4 level | 3 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0005994 | Nodular goiter | 3 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0000854 | Thyroid adenoma | 3 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0008225 | Thyroid follicular hyperplasia | 3 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0011787 | Central hypothyroidism | 3 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0000872 | Hashimoto thyroiditis | 3 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0000832 | Primary hypothyroidism | 3 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0002890 | Thyroid carcinoma | 3 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0031219 | Reduced radioactive iodine uptake | 3 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0005990 | Thyroid hypoplasia | 3 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0011791 | Inactivating thyroid-stimulating hormone receptor defect | 3 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0100028 | Ectopic thyroid | 3 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0031505 | Abnormal circulating T4 level | 3 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0011784 | Thyrotoxicosis with diffuse goiter | 3 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0011781 | Thyroid C cell hyperplasia | 3 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0000851 | Congenital hypothyroidism | 3 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0031220 | Increased radioactive iodine uptake | 3 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0011780 | Thyroid hemiagenesis | 3 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0011790 | Activating thyroid-stimulating hormone receptor defect | 3 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0033082 | Reduced TSH response to thyrotrophin-releasing hormone stimulation test | 3 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0009798 | Euthyroid goiter | 3 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0011783 | Thyrotoxicosis from ectopic thyroid tissue | 3 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0012558 | Abnormal T3/T4 ratio | 3 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0011786 | Thyrotoxicosis with toxic single thyroid nodule | 3 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0008223 | Compensated hypothyroidism | 3 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0008191 | Thyroid agenesis | 3 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0032209 | Abnormal circulating free T3 level | 3 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0033081 | Absent TSH response to thyrotrophin-releasing hormone stimulation test | 3 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0008251 | Congenital goiter | 3 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0011782 | Thyroid crisis | 3 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0011785 | Thyrotoxicosis with toxic multinodular goiter | 3 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0011787 | Central hypothyroidism | 3 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0033076 | Abnormal circulating free T4 level | 3 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0005994 | Nodular goiter | 3 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0000854 | Thyroid adenoma | 3 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0008225 | Thyroid follicular hyperplasia | 3 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0012560 | Decreased T3/T4 ratio | 4 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0011774 | Thyroid follicular adenoma | 4 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0040198 | Non-medullary thyroid carcinoma | 4 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0011788 | Increased circulating free T3 | 4 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0000866 | Euthyroid multinodular goiter | 4 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0033077 | Increased circulating free T4 level | 4 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0011773 | Uninodular goiter | 4 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0011778 | Thyroid atypical adenoma | 4 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0008245 | Pituitary hypothyroidism | 4 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0011777 | Thyroid papillary adenoma | 4 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0002865 | Medullary thyroid carcinoma | 4 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0032210 | Decreased circulating free T3 | 4 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0005987 | Multinodular goiter | 4 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0100029 | Lingual thyroid | 4 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0031506 | Increased circulating T4 level | 4 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0006781 | Hurthle cell thyroid adenoma | 4 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0008237 | Hypothalamic hypothyroidism | 4 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0006731 | Follicular thyroid carcinoma | 4 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0033078 | Decreased circulating free T4 level | 4 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0100030 | Accessory ectopic thyroid tissue | 4 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0031507 | Decreased circulating T4 level | 4 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0100647 | Graves disease | 4 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0012559 | Increased T3/T4 ratio | 4 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0011779 | Anaplastic thyroid carcinoma | 4 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0002895 | Papillary thyroid carcinoma | 4 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0011774 | Thyroid follicular adenoma | 4 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0040198 | Non-medullary thyroid carcinoma | 4 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0011788 | Increased circulating free T3 | 4 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0000866 | Euthyroid multinodular goiter | 4 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0012560 | Decreased T3/T4 ratio | 4 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0008245 | Pituitary hypothyroidism | 4 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0011777 | Thyroid papillary adenoma | 4 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0002865 | Medullary thyroid carcinoma | 4 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0032210 | Decreased circulating free T3 | 4 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0033077 | Increased circulating free T4 level | 4 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0011773 | Uninodular goiter | 4 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0011778 | Thyroid atypical adenoma | 4 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0008237 | Hypothalamic hypothyroidism | 4 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0006731 | Follicular thyroid carcinoma | 4 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0033078 | Decreased circulating free T4 level | 4 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0005987 | Multinodular goiter | 4 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0100029 | Lingual thyroid | 4 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0031506 | Increased circulating T4 level | 4 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0006781 | Hurthle cell thyroid adenoma | 4 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0011779 | Anaplastic thyroid carcinoma | 4 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0002895 | Papillary thyroid carcinoma | 4 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0100030 | Accessory ectopic thyroid tissue | 4 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0031507 | Decreased circulating T4 level | 4 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0100647 | Graves disease | 4 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0012559 | Increased T3/T4 ratio | 4 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0012560 | Decreased T3/T4 ratio | 4 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0011774 | Thyroid follicular adenoma | 4 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0040198 | Non-medullary thyroid carcinoma | 4 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0011788 | Increased circulating free T3 | 4 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0000866 | Euthyroid multinodular goiter | 4 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0011773 | Uninodular goiter | 4 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0011778 | Thyroid atypical adenoma | 4 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0008245 | Pituitary hypothyroidism | 4 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0011777 | Thyroid papillary adenoma | 4 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0002865 | Medullary thyroid carcinoma | 4 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0032210 | Decreased circulating free T3 | 4 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0033077 | Increased circulating free T4 level | 4 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0100029 | Lingual thyroid | 4 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0031506 | Increased circulating T4 level | 4 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0006781 | Hurthle cell thyroid adenoma | 4 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0008237 | Hypothalamic hypothyroidism | 4 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0006731 | Follicular thyroid carcinoma | 4 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0033078 | Decreased circulating free T4 level | 4 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0005987 | Multinodular goiter | 4 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0100030 | Accessory ectopic thyroid tissue | 4 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0031507 | Decreased circulating T4 level | 4 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0100647 | Graves disease | 4 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0012559 | Increased T3/T4 ratio | 4 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0011779 | Anaplastic thyroid carcinoma | 4 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0002895 | Papillary thyroid carcinoma | 4 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0002895 | Papillary thyroid carcinoma | 4 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0100030 | Accessory ectopic thyroid tissue | 4 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0031507 | Decreased circulating T4 level | 4 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0100647 | Graves disease | 4 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0012559 | Increased T3/T4 ratio | 4 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0011779 | Anaplastic thyroid carcinoma | 4 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0040198 | Non-medullary thyroid carcinoma | 4 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0011788 | Increased circulating free T3 | 4 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0000866 | Euthyroid multinodular goiter | 4 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0012560 | Decreased T3/T4 ratio | 4 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0011774 | Thyroid follicular adenoma | 4 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0002865 | Medullary thyroid carcinoma | 4 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0032210 | Decreased circulating free T3 | 4 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0033077 | Increased circulating free T4 level | 4 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0011773 | Uninodular goiter | 4 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0011778 | Thyroid atypical adenoma | 4 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0008245 | Pituitary hypothyroidism | 4 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0011777 | Thyroid papillary adenoma | 4 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0033078 | Decreased circulating free T4 level | 4 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0005987 | Multinodular goiter | 4 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0100029 | Lingual thyroid | 4 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0031506 | Increased circulating T4 level | 4 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0006781 | Hurthle cell thyroid adenoma | 4 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0008237 | Hypothalamic hypothyroidism | 4 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0006731 | Follicular thyroid carcinoma | 4 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0040198 | Non-medullary thyroid carcinoma | 4 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0011788 | Increased circulating free T3 | 4 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0000866 | Euthyroid multinodular goiter | 4 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0012560 | Decreased T3/T4 ratio | 4 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0011774 | Thyroid follicular adenoma | 4 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0032210 | Decreased circulating free T3 | 4 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0033077 | Increased circulating free T4 level | 4 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0011773 | Uninodular goiter | 4 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0011778 | Thyroid atypical adenoma | 4 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0008245 | Pituitary hypothyroidism | 4 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0011777 | Thyroid papillary adenoma | 4 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0002865 | Medullary thyroid carcinoma | 4 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0033078 | Decreased circulating free T4 level | 4 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0005987 | Multinodular goiter | 4 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0100029 | Lingual thyroid | 4 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0031506 | Increased circulating T4 level | 4 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0006781 | Hurthle cell thyroid adenoma | 4 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0008237 | Hypothalamic hypothyroidism | 4 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0006731 | Follicular thyroid carcinoma | 4 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0002895 | Papillary thyroid carcinoma | 4 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0100030 | Accessory ectopic thyroid tissue | 4 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0031507 | Decreased circulating T4 level | 4 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0100647 | Graves disease | 4 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0012559 | Increased T3/T4 ratio | 4 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0011779 | Anaplastic thyroid carcinoma | 4 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0012560 | Decreased T3/T4 ratio | 4 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0011774 | Thyroid follicular adenoma | 4 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0040198 | Non-medullary thyroid carcinoma | 4 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0011788 | Increased circulating free T3 | 4 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0000866 | Euthyroid multinodular goiter | 4 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0011778 | Thyroid atypical adenoma | 4 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0008245 | Pituitary hypothyroidism | 4 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0011777 | Thyroid papillary adenoma | 4 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0002865 | Medullary thyroid carcinoma | 4 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0032210 | Decreased circulating free T3 | 4 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0033077 | Increased circulating free T4 level | 4 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0011773 | Uninodular goiter | 4 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0006781 | Hurthle cell thyroid adenoma | 4 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0008237 | Hypothalamic hypothyroidism | 4 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0006731 | Follicular thyroid carcinoma | 4 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0033078 | Decreased circulating free T4 level | 4 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0005987 | Multinodular goiter | 4 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0100029 | Lingual thyroid | 4 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0031506 | Increased circulating T4 level | 4 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0012559 | Increased T3/T4 ratio | 4 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0011779 | Anaplastic thyroid carcinoma | 4 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0002895 | Papillary thyroid carcinoma | 4 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0100030 | Accessory ectopic thyroid tissue | 4 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0031507 | Decreased circulating T4 level | 4 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0100647 | Graves disease | 4 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0040198 | Non-medullary thyroid carcinoma | 4 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0011788 | Increased circulating free T3 | 4 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0000866 | Euthyroid multinodular goiter | 4 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0012560 | Decreased T3/T4 ratio | 4 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0011774 | Thyroid follicular adenoma | 4 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0011777 | Thyroid papillary adenoma | 4 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0002865 | Medullary thyroid carcinoma | 4 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0032210 | Decreased circulating free T3 | 4 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0033077 | Increased circulating free T4 level | 4 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0011773 | Uninodular goiter | 4 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0011778 | Thyroid atypical adenoma | 4 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0008245 | Pituitary hypothyroidism | 4 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0006731 | Follicular thyroid carcinoma | 4 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0033078 | Decreased circulating free T4 level | 4 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0005987 | Multinodular goiter | 4 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0100029 | Lingual thyroid | 4 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0031506 | Increased circulating T4 level | 4 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0006781 | Hurthle cell thyroid adenoma | 4 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0008237 | Hypothalamic hypothyroidism | 4 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0011779 | Anaplastic thyroid carcinoma | 4 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0002895 | Papillary thyroid carcinoma | 4 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0100030 | Accessory ectopic thyroid tissue | 4 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0031507 | Decreased circulating T4 level | 4 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0100647 | Graves disease | 4 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0012559 | Increased T3/T4 ratio | 4 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0012560 | Decreased T3/T4 ratio | 4 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0011774 | Thyroid follicular adenoma | 4 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0040198 | Non-medullary thyroid carcinoma | 4 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0011788 | Increased circulating free T3 | 4 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0000866 | Euthyroid multinodular goiter | 4 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0011778 | Thyroid atypical adenoma | 4 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0008245 | Pituitary hypothyroidism | 4 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0011777 | Thyroid papillary adenoma | 4 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0002865 | Medullary thyroid carcinoma | 4 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0032210 | Decreased circulating free T3 | 4 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0033077 | Increased circulating free T4 level | 4 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0011773 | Uninodular goiter | 4 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0031506 | Increased circulating T4 level | 4 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0006781 | Hurthle cell thyroid adenoma | 4 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0008237 | Hypothalamic hypothyroidism | 4 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0006731 | Follicular thyroid carcinoma | 4 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0033078 | Decreased circulating free T4 level | 4 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0005987 | Multinodular goiter | 4 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0100029 | Lingual thyroid | 4 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0012559 | Increased T3/T4 ratio | 4 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0011779 | Anaplastic thyroid carcinoma | 4 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0002895 | Papillary thyroid carcinoma | 4 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0100030 | Accessory ectopic thyroid tissue | 4 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0031507 | Decreased circulating T4 level | 4 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0100647 | Graves disease | 4 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0012560 | Decreased T3/T4 ratio | 4 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0011774 | Thyroid follicular adenoma | 4 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0040198 | Non-medullary thyroid carcinoma | 4 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0011788 | Increased circulating free T3 | 4 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0000866 | Euthyroid multinodular goiter | 4 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0033077 | Increased circulating free T4 level | 4 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0011773 | Uninodular goiter | 4 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0011778 | Thyroid atypical adenoma | 4 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0008245 | Pituitary hypothyroidism | 4 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0011777 | Thyroid papillary adenoma | 4 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0002865 | Medullary thyroid carcinoma | 4 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0032210 | Decreased circulating free T3 | 4 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0033078 | Decreased circulating free T4 level | 4 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0005987 | Multinodular goiter | 4 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0100029 | Lingual thyroid | 4 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0031506 | Increased circulating T4 level | 4 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0006781 | Hurthle cell thyroid adenoma | 4 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0008237 | Hypothalamic hypothyroidism | 4 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0006731 | Follicular thyroid carcinoma | 4 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0100030 | Accessory ectopic thyroid tissue | 4 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0031507 | Decreased circulating T4 level | 4 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0100647 | Graves disease | 4 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0012559 | Increased T3/T4 ratio | 4 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0011779 | Anaplastic thyroid carcinoma | 4 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0002895 | Papillary thyroid carcinoma | 4 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0000866 | Euthyroid multinodular goiter | 4 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0012560 | Decreased T3/T4 ratio | 4 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0011774 | Thyroid follicular adenoma | 4 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0040198 | Non-medullary thyroid carcinoma | 4 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0011788 | Increased circulating free T3 | 4 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0033077 | Increased circulating free T4 level | 4 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0011773 | Uninodular goiter | 4 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0011778 | Thyroid atypical adenoma | 4 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0008245 | Pituitary hypothyroidism | 4 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0011777 | Thyroid papillary adenoma | 4 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0002865 | Medullary thyroid carcinoma | 4 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0032210 | Decreased circulating free T3 | 4 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0033078 | Decreased circulating free T4 level | 4 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0005987 | Multinodular goiter | 4 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0100029 | Lingual thyroid | 4 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0031506 | Increased circulating T4 level | 4 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0006781 | Hurthle cell thyroid adenoma | 4 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0008237 | Hypothalamic hypothyroidism | 4 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0006731 | Follicular thyroid carcinoma | 4 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0100030 | Accessory ectopic thyroid tissue | 4 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0031507 | Decreased circulating T4 level | 4 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0100647 | Graves disease | 4 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0012559 | Increased T3/T4 ratio | 4 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0011779 | Anaplastic thyroid carcinoma | 4 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0002895 | Papillary thyroid carcinoma | 4 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0031507 | Decreased circulating T4 level | 4 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0100647 | Graves disease | 4 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0012559 | Increased T3/T4 ratio | 4 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0011779 | Anaplastic thyroid carcinoma | 4 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0002895 | Papillary thyroid carcinoma | 4 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0100030 | Accessory ectopic thyroid tissue | 4 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0012560 | Decreased T3/T4 ratio | 4 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0011774 | Thyroid follicular adenoma | 4 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0040198 | Non-medullary thyroid carcinoma | 4 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0011788 | Increased circulating free T3 | 4 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0000866 | Euthyroid multinodular goiter | 4 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0011773 | Uninodular goiter | 4 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0011778 | Thyroid atypical adenoma | 4 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0008245 | Pituitary hypothyroidism | 4 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0011777 | Thyroid papillary adenoma | 4 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0002865 | Medullary thyroid carcinoma | 4 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0032210 | Decreased circulating free T3 | 4 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0033077 | Increased circulating free T4 level | 4 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0100029 | Lingual thyroid | 4 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0031506 | Increased circulating T4 level | 4 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0006781 | Hurthle cell thyroid adenoma | 4 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0008237 | Hypothalamic hypothyroidism | 4 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0006731 | Follicular thyroid carcinoma | 4 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0033078 | Decreased circulating free T4 level | 4 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0005987 | Multinodular goiter | 4 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0040198 | Non-medullary thyroid carcinoma | 4 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0011788 | Increased circulating free T3 | 4 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0000866 | Euthyroid multinodular goiter | 4 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0012560 | Decreased T3/T4 ratio | 4 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0011774 | Thyroid follicular adenoma | 4 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0002865 | Medullary thyroid carcinoma | 4 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0032210 | Decreased circulating free T3 | 4 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0033077 | Increased circulating free T4 level | 4 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0011773 | Uninodular goiter | 4 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0011778 | Thyroid atypical adenoma | 4 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0008245 | Pituitary hypothyroidism | 4 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0011777 | Thyroid papillary adenoma | 4 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0006731 | Follicular thyroid carcinoma | 4 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0033078 | Decreased circulating free T4 level | 4 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0005987 | Multinodular goiter | 4 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0100029 | Lingual thyroid | 4 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0031506 | Increased circulating T4 level | 4 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0006781 | Hurthle cell thyroid adenoma | 4 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0008237 | Hypothalamic hypothyroidism | 4 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0011779 | Anaplastic thyroid carcinoma | 4 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0002895 | Papillary thyroid carcinoma | 4 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0100030 | Accessory ectopic thyroid tissue | 4 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0031507 | Decreased circulating T4 level | 4 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0100647 | Graves disease | 4 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0012559 | Increased T3/T4 ratio | 4 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0012560 | Decreased T3/T4 ratio | 4 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0011774 | Thyroid follicular adenoma | 4 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0040198 | Non-medullary thyroid carcinoma | 4 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0011788 | Increased circulating free T3 | 4 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0000866 | Euthyroid multinodular goiter | 4 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0011778 | Thyroid atypical adenoma | 4 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0008245 | Pituitary hypothyroidism | 4 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0011777 | Thyroid papillary adenoma | 4 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0002865 | Medullary thyroid carcinoma | 4 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0032210 | Decreased circulating free T3 | 4 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0033077 | Increased circulating free T4 level | 4 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0011773 | Uninodular goiter | 4 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0008237 | Hypothalamic hypothyroidism | 4 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0006731 | Follicular thyroid carcinoma | 4 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0033078 | Decreased circulating free T4 level | 4 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0005987 | Multinodular goiter | 4 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0100029 | Lingual thyroid | 4 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0031506 | Increased circulating T4 level | 4 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0006781 | Hurthle cell thyroid adenoma | 4 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0012559 | Increased T3/T4 ratio | 4 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0011779 | Anaplastic thyroid carcinoma | 4 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0002895 | Papillary thyroid carcinoma | 4 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0100030 | Accessory ectopic thyroid tissue | 4 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0031507 | Decreased circulating T4 level | 4 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0100647 | Graves disease | 4 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0011776 | Thyroid microfollicular adenoma | 5 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0011775 | Thyroid macrofollicular adenoma | 5 | CASR CL E G H | 846 | 417 | Aloi Tomasini Isaia syndrome | | | ORPHA | 1 | | 2330 | 1514 | 601199 |
HP:0000820 | HP:0011776 | Thyroid microfollicular adenoma | 5 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0011775 | Thyroid macrofollicular adenoma | 5 | IL12A CL E G H | 3592 | 186 | | | | ORPHA | 1 | | 34 | 5969 | 161560 |
HP:0000820 | HP:0011776 | Thyroid microfollicular adenoma | 5 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0011775 | Thyroid macrofollicular adenoma | 5 | IL12RB1 CL E G H | 3594 | 186 | | | | ORPHA | 1 | | 465 | 5971 | 601604 |
HP:0000820 | HP:0011775 | Thyroid macrofollicular adenoma | 5 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0011776 | Thyroid microfollicular adenoma | 5 | INSR CL E G H | 3643 | 769 | | | | ORPHA | 1 | | 622 | 6091 | 147670 |
HP:0000820 | HP:0011776 | Thyroid microfollicular adenoma | 5 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0011775 | Thyroid macrofollicular adenoma | 5 | IRF5 CL E G H | 3663 | 186 | | | | ORPHA | 1 | | 65 | 6120 | 607218 |
HP:0000820 | HP:0011776 | Thyroid microfollicular adenoma | 5 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0011775 | Thyroid macrofollicular adenoma | 5 | MEN1 CL E G H | 4221 | 131100 | Multiple endocrine neoplasia, type 1 | 131100 | C0025267 | OMIM | 1 | | 2173 | 7010 | 613733 |
HP:0000820 | HP:0011776 | Thyroid microfollicular adenoma | 5 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0011775 | Thyroid macrofollicular adenoma | 5 | MMEL1 CL E G H | 79258 | 186 | | | | ORPHA | 1 | | 181 | 14668 | 618104 |
HP:0000820 | HP:0011776 | Thyroid microfollicular adenoma | 5 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0011775 | Thyroid macrofollicular adenoma | 5 | POU2AF1 CL E G H | 5450 | 186 | | | | ORPHA | 1 | | 39 | 9211 | 601206 |
HP:0000820 | HP:0011776 | Thyroid microfollicular adenoma | 5 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0011775 | Thyroid macrofollicular adenoma | 5 | RAI1 CL E G H | 10743 | 182290 | Smith-Magenis syndrome | 182290 | C0795864 | OMIM | 1 | | 1608 | 9834 | 607642 |
HP:0000820 | HP:0011776 | Thyroid microfollicular adenoma | 5 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0011775 | Thyroid macrofollicular adenoma | 5 | SPIB CL E G H | 6689 | 186 | | | | ORPHA | 1 | | 34 | 11242 | 606802 |
HP:0000820 | HP:0011775 | Thyroid macrofollicular adenoma | 5 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0011776 | Thyroid microfollicular adenoma | 5 | THRB CL E G H | 7068 | 3221 | Leisti Hollister Rimoin syndrome | | | ORPHA | 1 | | 348 | 11799 | 190160 |
HP:0000820 | HP:0011776 | Thyroid microfollicular adenoma | 5 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0011775 | Thyroid macrofollicular adenoma | 5 | TNFSF15 CL E G H | 9966 | 186 | | | | ORPHA | 1 | | 50 | 11931 | 604052 |
HP:0000820 | HP:0011776 | Thyroid microfollicular adenoma | 5 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HP:0000820 | HP:0011775 | Thyroid macrofollicular adenoma | 5 | TNPO3 CL E G H | 23534 | 186 | | | | ORPHA | 1 | | 575 | 17103 | 610032 |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0000820 | HP:0000820 | Abnormality of the thyroid gland | 0 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0000820 | Abnormality of the thyroid gland | 0 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0000820 | Abnormality of the thyroid gland | 0 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0000820 | Abnormality of the thyroid gland | 0 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0000820 | Abnormality of the thyroid gland | 0 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0000820 | Abnormality of the thyroid gland | 0 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0000820 | Abnormality of the thyroid gland | 0 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0002926 | Abnormality of thyroid physiology | 1 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0011772 | Abnormal thyroid morphology | 1 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0002926 | Abnormality of thyroid physiology | 1 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0011772 | Abnormal thyroid morphology | 1 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0002926 | Abnormality of thyroid physiology | 1 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0011772 | Abnormal thyroid morphology | 1 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0002926 | Abnormality of thyroid physiology | 1 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0011772 | Abnormal thyroid morphology | 1 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0002926 | Abnormality of thyroid physiology | 1 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0011772 | Abnormal thyroid morphology | 1 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0011772 | Abnormal thyroid morphology | 1 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0002926 | Abnormality of thyroid physiology | 1 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0002926 | Abnormality of thyroid physiology | 1 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0011772 | Abnormal thyroid morphology | 1 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0000836 | Hyperthyroidism | 2 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0033079 | Aplasia/Hypoplasia of the thyroid gland | 2 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0002930 | Impaired sensitivity to thyroid hormone | 2 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0031508 | Abnormal thyroid hormone level | 2 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0033080 | Abnormal TSH response to thyrotrophin-releasing hormone stimulation test | 2 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0000853 | Goiter | 2 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0025482 | Positive perchlorate discharge test | 2 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0008247 | Euthyroid hyperthyroxinemia | 2 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0100031 | Neoplasm of the thyroid gland | 2 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0000821 | Hypothyroidism | 2 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0008229 | Thyroid lymphangiectasia | 2 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0008188 | Thyroid dysgenesis | 2 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0008249 | Thyroid hyperplasia | 2 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0100646 | Thyroiditis | 2 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0008263 | Thyroid defect in oxidation and organification of iodide | 2 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0010518 | Thyroglossal cyst | 2 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0025388 | Thyroid nodule | 2 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0031221 | Abnormal radioactive iodine uptake test result | 2 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0011789 | Impaired sensitivity to thyroid stimulating hormone | 2 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0033079 | Aplasia/Hypoplasia of the thyroid gland | 2 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0002930 | Impaired sensitivity to thyroid hormone | 2 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0031508 | Abnormal thyroid hormone level | 2 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0033080 | Abnormal TSH response to thyrotrophin-releasing hormone stimulation test | 2 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0000853 | Goiter | 2 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0025482 | Positive perchlorate discharge test | 2 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0000836 | Hyperthyroidism | 2 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0008229 | Thyroid lymphangiectasia | 2 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0008247 | Euthyroid hyperthyroxinemia | 2 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0100031 | Neoplasm of the thyroid gland | 2 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0000821 | Hypothyroidism | 2 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0008188 | Thyroid dysgenesis | 2 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0008249 | Thyroid hyperplasia | 2 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0100646 | Thyroiditis | 2 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0031221 | Abnormal radioactive iodine uptake test result | 2 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0011789 | Impaired sensitivity to thyroid stimulating hormone | 2 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0008263 | Thyroid defect in oxidation and organification of iodide | 2 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0010518 | Thyroglossal cyst | 2 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0025388 | Thyroid nodule | 2 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0033079 | Aplasia/Hypoplasia of the thyroid gland | 2 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0031508 | Abnormal thyroid hormone level | 2 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0033080 | Abnormal TSH response to thyrotrophin-releasing hormone stimulation test | 2 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0000853 | Goiter | 2 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0002930 | Impaired sensitivity to thyroid hormone | 2 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0025482 | Positive perchlorate discharge test | 2 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0000836 | Hyperthyroidism | 2 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0008229 | Thyroid lymphangiectasia | 2 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0100031 | Neoplasm of the thyroid gland | 2 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0000821 | Hypothyroidism | 2 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0008247 | Euthyroid hyperthyroxinemia | 2 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0100646 | Thyroiditis | 2 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0008188 | Thyroid dysgenesis | 2 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0008249 | Thyroid hyperplasia | 2 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0025388 | Thyroid nodule | 2 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0031221 | Abnormal radioactive iodine uptake test result | 2 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0010518 | Thyroglossal cyst | 2 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0011789 | Impaired sensitivity to thyroid stimulating hormone | 2 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0008263 | Thyroid defect in oxidation and organification of iodide | 2 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0000836 | Hyperthyroidism | 2 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0033079 | Aplasia/Hypoplasia of the thyroid gland | 2 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0002930 | Impaired sensitivity to thyroid hormone | 2 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0031508 | Abnormal thyroid hormone level | 2 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0033080 | Abnormal TSH response to thyrotrophin-releasing hormone stimulation test | 2 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0000853 | Goiter | 2 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0025482 | Positive perchlorate discharge test | 2 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0100031 | Neoplasm of the thyroid gland | 2 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0000821 | Hypothyroidism | 2 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0008229 | Thyroid lymphangiectasia | 2 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0008247 | Euthyroid hyperthyroxinemia | 2 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0008188 | Thyroid dysgenesis | 2 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0008249 | Thyroid hyperplasia | 2 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0100646 | Thyroiditis | 2 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0010518 | Thyroglossal cyst | 2 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0025388 | Thyroid nodule | 2 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0031221 | Abnormal radioactive iodine uptake test result | 2 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0011789 | Impaired sensitivity to thyroid stimulating hormone | 2 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0008263 | Thyroid defect in oxidation and organification of iodide | 2 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0031508 | Abnormal thyroid hormone level | 2 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0033080 | Abnormal TSH response to thyrotrophin-releasing hormone stimulation test | 2 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0000853 | Goiter | 2 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0025482 | Positive perchlorate discharge test | 2 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0000836 | Hyperthyroidism | 2 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0033079 | Aplasia/Hypoplasia of the thyroid gland | 2 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0002930 | Impaired sensitivity to thyroid hormone | 2 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0008229 | Thyroid lymphangiectasia | 2 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0008247 | Euthyroid hyperthyroxinemia | 2 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0100031 | Neoplasm of the thyroid gland | 2 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0000821 | Hypothyroidism | 2 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0008188 | Thyroid dysgenesis | 2 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0008249 | Thyroid hyperplasia | 2 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0100646 | Thyroiditis | 2 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0011789 | Impaired sensitivity to thyroid stimulating hormone | 2 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0008263 | Thyroid defect in oxidation and organification of iodide | 2 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0010518 | Thyroglossal cyst | 2 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0025388 | Thyroid nodule | 2 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0031221 | Abnormal radioactive iodine uptake test result | 2 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0008229 | Thyroid lymphangiectasia | 2 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0008247 | Euthyroid hyperthyroxinemia | 2 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0100031 | Neoplasm of the thyroid gland | 2 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0000821 | Hypothyroidism | 2 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0008188 | Thyroid dysgenesis | 2 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0008249 | Thyroid hyperplasia | 2 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0100646 | Thyroiditis | 2 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0008263 | Thyroid defect in oxidation and organification of iodide | 2 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0010518 | Thyroglossal cyst | 2 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0025388 | Thyroid nodule | 2 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0031221 | Abnormal radioactive iodine uptake test result | 2 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0011789 | Impaired sensitivity to thyroid stimulating hormone | 2 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0031508 | Abnormal thyroid hormone level | 2 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0033080 | Abnormal TSH response to thyrotrophin-releasing hormone stimulation test | 2 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0000853 | Goiter | 2 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0025482 | Positive perchlorate discharge test | 2 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0000836 | Hyperthyroidism | 2 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0033079 | Aplasia/Hypoplasia of the thyroid gland | 2 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0002930 | Impaired sensitivity to thyroid hormone | 2 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0033079 | Aplasia/Hypoplasia of the thyroid gland | 2 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0002930 | Impaired sensitivity to thyroid hormone | 2 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0031508 | Abnormal thyroid hormone level | 2 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0033080 | Abnormal TSH response to thyrotrophin-releasing hormone stimulation test | 2 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0000853 | Goiter | 2 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0025482 | Positive perchlorate discharge test | 2 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0000836 | Hyperthyroidism | 2 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0008229 | Thyroid lymphangiectasia | 2 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0008247 | Euthyroid hyperthyroxinemia | 2 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0100031 | Neoplasm of the thyroid gland | 2 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0000821 | Hypothyroidism | 2 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0008188 | Thyroid dysgenesis | 2 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0008249 | Thyroid hyperplasia | 2 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0100646 | Thyroiditis | 2 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0031221 | Abnormal radioactive iodine uptake test result | 2 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0011789 | Impaired sensitivity to thyroid stimulating hormone | 2 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0008263 | Thyroid defect in oxidation and organification of iodide | 2 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0010518 | Thyroglossal cyst | 2 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0025388 | Thyroid nodule | 2 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0033076 | Abnormal circulating free T4 level | 3 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0005994 | Nodular goiter | 3 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0000854 | Thyroid adenoma | 3 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0008225 | Thyroid follicular hyperplasia | 3 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0011787 | Central hypothyroidism | 3 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0100028 | Ectopic thyroid | 3 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0031505 | Abnormal circulating T4 level | 3 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0011784 | Thyrotoxicosis with diffuse goiter | 3 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0011781 | Thyroid C cell hyperplasia | 3 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0000872 | Hashimoto thyroiditis | 3 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0000832 | Primary hypothyroidism | 3 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0002890 | Thyroid carcinoma | 3 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0031219 | Reduced radioactive iodine uptake | 3 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0005990 | Thyroid hypoplasia | 3 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0011791 | Inactivating thyroid-stimulating hormone receptor defect | 3 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0033082 | Reduced TSH response to thyrotrophin-releasing hormone stimulation test | 3 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0009798 | Euthyroid goiter | 3 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0011783 | Thyrotoxicosis from ectopic thyroid tissue | 3 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0012558 | Abnormal T3/T4 ratio | 3 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0011786 | Thyrotoxicosis with toxic single thyroid nodule | 3 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0000851 | Congenital hypothyroidism | 3 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0031220 | Increased radioactive iodine uptake | 3 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0011780 | Thyroid hemiagenesis | 3 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0011790 | Activating thyroid-stimulating hormone receptor defect | 3 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0008251 | Congenital goiter | 3 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0011782 | Thyroid crisis | 3 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0011785 | Thyrotoxicosis with toxic multinodular goiter | 3 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0008223 | Compensated hypothyroidism | 3 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0008191 | Thyroid agenesis | 3 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0032209 | Abnormal circulating free T3 level | 3 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0033081 | Absent TSH response to thyrotrophin-releasing hormone stimulation test | 3 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0033076 | Abnormal circulating free T4 level | 3 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0005994 | Nodular goiter | 3 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0000854 | Thyroid adenoma | 3 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0008225 | Thyroid follicular hyperplasia | 3 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0011787 | Central hypothyroidism | 3 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0000832 | Primary hypothyroidism | 3 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0002890 | Thyroid carcinoma | 3 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0031219 | Reduced radioactive iodine uptake | 3 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0005990 | Thyroid hypoplasia | 3 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0011791 | Inactivating thyroid-stimulating hormone receptor defect | 3 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0100028 | Ectopic thyroid | 3 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0031505 | Abnormal circulating T4 level | 3 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0011784 | Thyrotoxicosis with diffuse goiter | 3 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0011781 | Thyroid C cell hyperplasia | 3 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0000872 | Hashimoto thyroiditis | 3 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0031220 | Increased radioactive iodine uptake | 3 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0011780 | Thyroid hemiagenesis | 3 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0011790 | Activating thyroid-stimulating hormone receptor defect | 3 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0033082 | Reduced TSH response to thyrotrophin-releasing hormone stimulation test | 3 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0009798 | Euthyroid goiter | 3 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0011783 | Thyrotoxicosis from ectopic thyroid tissue | 3 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0012558 | Abnormal T3/T4 ratio | 3 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0011786 | Thyrotoxicosis with toxic single thyroid nodule | 3 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0000851 | Congenital hypothyroidism | 3 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0008191 | Thyroid agenesis | 3 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0032209 | Abnormal circulating free T3 level | 3 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0033081 | Absent TSH response to thyrotrophin-releasing hormone stimulation test | 3 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0008251 | Congenital goiter | 3 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0011782 | Thyroid crisis | 3 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0011785 | Thyrotoxicosis with toxic multinodular goiter | 3 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0008223 | Compensated hypothyroidism | 3 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0000854 | Thyroid adenoma | 3 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0008225 | Thyroid follicular hyperplasia | 3 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0033076 | Abnormal circulating free T4 level | 3 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0005994 | Nodular goiter | 3 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0011787 | Central hypothyroidism | 3 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0011781 | Thyroid C cell hyperplasia | 3 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0000872 | Hashimoto thyroiditis | 3 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0002890 | Thyroid carcinoma | 3 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0031219 | Reduced radioactive iodine uptake | 3 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0005990 | Thyroid hypoplasia | 3 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0100028 | Ectopic thyroid | 3 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0031505 | Abnormal circulating T4 level | 3 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0000832 | Primary hypothyroidism | 3 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0011791 | Inactivating thyroid-stimulating hormone receptor defect | 3 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0011784 | Thyrotoxicosis with diffuse goiter | 3 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0012558 | Abnormal T3/T4 ratio | 3 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0031220 | Increased radioactive iodine uptake | 3 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0011780 | Thyroid hemiagenesis | 3 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0009798 | Euthyroid goiter | 3 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0011786 | Thyrotoxicosis with toxic single thyroid nodule | 3 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0000851 | Congenital hypothyroidism | 3 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0011790 | Activating thyroid-stimulating hormone receptor defect | 3 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0033082 | Reduced TSH response to thyrotrophin-releasing hormone stimulation test | 3 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0011783 | Thyrotoxicosis from ectopic thyroid tissue | 3 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0008191 | Thyroid agenesis | 3 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0032209 | Abnormal circulating free T3 level | 3 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0033081 | Absent TSH response to thyrotrophin-releasing hormone stimulation test | 3 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0008251 | Congenital goiter | 3 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0011785 | Thyrotoxicosis with toxic multinodular goiter | 3 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0008223 | Compensated hypothyroidism | 3 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0011782 | Thyroid crisis | 3 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0033076 | Abnormal circulating free T4 level | 3 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0005994 | Nodular goiter | 3 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0000854 | Thyroid adenoma | 3 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0008225 | Thyroid follicular hyperplasia | 3 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0011787 | Central hypothyroidism | 3 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0100028 | Ectopic thyroid | 3 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0031505 | Abnormal circulating T4 level | 3 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0011784 | Thyrotoxicosis with diffuse goiter | 3 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0011781 | Thyroid C cell hyperplasia | 3 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0000872 | Hashimoto thyroiditis | 3 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0000832 | Primary hypothyroidism | 3 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0002890 | Thyroid carcinoma | 3 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0031219 | Reduced radioactive iodine uptake | 3 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0005990 | Thyroid hypoplasia | 3 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0011791 | Inactivating thyroid-stimulating hormone receptor defect | 3 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0011783 | Thyrotoxicosis from ectopic thyroid tissue | 3 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0012558 | Abnormal T3/T4 ratio | 3 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0011786 | Thyrotoxicosis with toxic single thyroid nodule | 3 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0000851 | Congenital hypothyroidism | 3 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0031220 | Increased radioactive iodine uptake | 3 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0011780 | Thyroid hemiagenesis | 3 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0011790 | Activating thyroid-stimulating hormone receptor defect | 3 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0033082 | Reduced TSH response to thyrotrophin-releasing hormone stimulation test | 3 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0009798 | Euthyroid goiter | 3 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0011782 | Thyroid crisis | 3 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0011785 | Thyrotoxicosis with toxic multinodular goiter | 3 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0008223 | Compensated hypothyroidism | 3 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0008191 | Thyroid agenesis | 3 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0032209 | Abnormal circulating free T3 level | 3 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0033081 | Absent TSH response to thyrotrophin-releasing hormone stimulation test | 3 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0008251 | Congenital goiter | 3 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0033076 | Abnormal circulating free T4 level | 3 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0005994 | Nodular goiter | 3 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0000854 | Thyroid adenoma | 3 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0008225 | Thyroid follicular hyperplasia | 3 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0011787 | Central hypothyroidism | 3 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0031219 | Reduced radioactive iodine uptake | 3 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0005990 | Thyroid hypoplasia | 3 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0011791 | Inactivating thyroid-stimulating hormone receptor defect | 3 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0100028 | Ectopic thyroid | 3 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0031505 | Abnormal circulating T4 level | 3 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0011784 | Thyrotoxicosis with diffuse goiter | 3 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0011781 | Thyroid C cell hyperplasia | 3 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0000872 | Hashimoto thyroiditis | 3 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0000832 | Primary hypothyroidism | 3 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0002890 | Thyroid carcinoma | 3 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0031220 | Increased radioactive iodine uptake | 3 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0011780 | Thyroid hemiagenesis | 3 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0011790 | Activating thyroid-stimulating hormone receptor defect | 3 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0033082 | Reduced TSH response to thyrotrophin-releasing hormone stimulation test | 3 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0009798 | Euthyroid goiter | 3 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0011783 | Thyrotoxicosis from ectopic thyroid tissue | 3 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0012558 | Abnormal T3/T4 ratio | 3 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0011786 | Thyrotoxicosis with toxic single thyroid nodule | 3 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0000851 | Congenital hypothyroidism | 3 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0008191 | Thyroid agenesis | 3 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0032209 | Abnormal circulating free T3 level | 3 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0033081 | Absent TSH response to thyrotrophin-releasing hormone stimulation test | 3 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0008251 | Congenital goiter | 3 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0011782 | Thyroid crisis | 3 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0011785 | Thyrotoxicosis with toxic multinodular goiter | 3 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0008223 | Compensated hypothyroidism | 3 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0031219 | Reduced radioactive iodine uptake | 3 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0005990 | Thyroid hypoplasia | 3 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0011791 | Inactivating thyroid-stimulating hormone receptor defect | 3 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0100028 | Ectopic thyroid | 3 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0031505 | Abnormal circulating T4 level | 3 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0011784 | Thyrotoxicosis with diffuse goiter | 3 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0011781 | Thyroid C cell hyperplasia | 3 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0000872 | Hashimoto thyroiditis | 3 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0000832 | Primary hypothyroidism | 3 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0002890 | Thyroid carcinoma | 3 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0011780 | Thyroid hemiagenesis | 3 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0011790 | Activating thyroid-stimulating hormone receptor defect | 3 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0033082 | Reduced TSH response to thyrotrophin-releasing hormone stimulation test | 3 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0009798 | Euthyroid goiter | 3 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0011783 | Thyrotoxicosis from ectopic thyroid tissue | 3 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0012558 | Abnormal T3/T4 ratio | 3 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0011786 | Thyrotoxicosis with toxic single thyroid nodule | 3 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0000851 | Congenital hypothyroidism | 3 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0031220 | Increased radioactive iodine uptake | 3 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0032209 | Abnormal circulating free T3 level | 3 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0033081 | Absent TSH response to thyrotrophin-releasing hormone stimulation test | 3 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0008251 | Congenital goiter | 3 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0011782 | Thyroid crisis | 3 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0011785 | Thyrotoxicosis with toxic multinodular goiter | 3 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0008223 | Compensated hypothyroidism | 3 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0008191 | Thyroid agenesis | 3 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0033076 | Abnormal circulating free T4 level | 3 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0005994 | Nodular goiter | 3 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0000854 | Thyroid adenoma | 3 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0008225 | Thyroid follicular hyperplasia | 3 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0011787 | Central hypothyroidism | 3 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0033076 | Abnormal circulating free T4 level | 3 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0005994 | Nodular goiter | 3 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0000854 | Thyroid adenoma | 3 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0008225 | Thyroid follicular hyperplasia | 3 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0011787 | Central hypothyroidism | 3 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0000872 | Hashimoto thyroiditis | 3 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0000832 | Primary hypothyroidism | 3 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0002890 | Thyroid carcinoma | 3 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0031219 | Reduced radioactive iodine uptake | 3 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0005990 | Thyroid hypoplasia | 3 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0011791 | Inactivating thyroid-stimulating hormone receptor defect | 3 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0100028 | Ectopic thyroid | 3 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0031505 | Abnormal circulating T4 level | 3 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0011784 | Thyrotoxicosis with diffuse goiter | 3 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0011781 | Thyroid C cell hyperplasia | 3 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0000851 | Congenital hypothyroidism | 3 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0031220 | Increased radioactive iodine uptake | 3 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0011780 | Thyroid hemiagenesis | 3 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0011790 | Activating thyroid-stimulating hormone receptor defect | 3 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0033082 | Reduced TSH response to thyrotrophin-releasing hormone stimulation test | 3 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0009798 | Euthyroid goiter | 3 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0011783 | Thyrotoxicosis from ectopic thyroid tissue | 3 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0012558 | Abnormal T3/T4 ratio | 3 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0011786 | Thyrotoxicosis with toxic single thyroid nodule | 3 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0008223 | Compensated hypothyroidism | 3 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0008191 | Thyroid agenesis | 3 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0032209 | Abnormal circulating free T3 level | 3 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0033081 | Absent TSH response to thyrotrophin-releasing hormone stimulation test | 3 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0008251 | Congenital goiter | 3 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0011782 | Thyroid crisis | 3 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0011785 | Thyrotoxicosis with toxic multinodular goiter | 3 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0002895 | Papillary thyroid carcinoma | 4 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0100030 | Accessory ectopic thyroid tissue | 4 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0031507 | Decreased circulating T4 level | 4 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0100647 | Graves disease | 4 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0012559 | Increased T3/T4 ratio | 4 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0011779 | Anaplastic thyroid carcinoma | 4 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0011788 | Increased circulating free T3 | 4 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0000866 | Euthyroid multinodular goiter | 4 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0012560 | Decreased T3/T4 ratio | 4 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0011774 | Thyroid follicular adenoma | 4 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0040198 | Non-medullary thyroid carcinoma | 4 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0032210 | Decreased circulating free T3 | 4 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0033077 | Increased circulating free T4 level | 4 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0011773 | Uninodular goiter | 4 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0011778 | Thyroid atypical adenoma | 4 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0008245 | Pituitary hypothyroidism | 4 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0011777 | Thyroid papillary adenoma | 4 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0002865 | Medullary thyroid carcinoma | 4 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0033078 | Decreased circulating free T4 level | 4 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0005987 | Multinodular goiter | 4 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0100029 | Lingual thyroid | 4 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0031506 | Increased circulating T4 level | 4 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0006781 | Hurthle cell thyroid adenoma | 4 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0008237 | Hypothalamic hypothyroidism | 4 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0006731 | Follicular thyroid carcinoma | 4 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0011779 | Anaplastic thyroid carcinoma | 4 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0002895 | Papillary thyroid carcinoma | 4 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0100030 | Accessory ectopic thyroid tissue | 4 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0031507 | Decreased circulating T4 level | 4 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0100647 | Graves disease | 4 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0012559 | Increased T3/T4 ratio | 4 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0040198 | Non-medullary thyroid carcinoma | 4 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0011788 | Increased circulating free T3 | 4 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0000866 | Euthyroid multinodular goiter | 4 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0012560 | Decreased T3/T4 ratio | 4 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0011774 | Thyroid follicular adenoma | 4 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0011777 | Thyroid papillary adenoma | 4 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0002865 | Medullary thyroid carcinoma | 4 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0032210 | Decreased circulating free T3 | 4 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0033077 | Increased circulating free T4 level | 4 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0011773 | Uninodular goiter | 4 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0011778 | Thyroid atypical adenoma | 4 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0008245 | Pituitary hypothyroidism | 4 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0006731 | Follicular thyroid carcinoma | 4 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0033078 | Decreased circulating free T4 level | 4 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0005987 | Multinodular goiter | 4 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0100029 | Lingual thyroid | 4 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0031506 | Increased circulating T4 level | 4 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0006781 | Hurthle cell thyroid adenoma | 4 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0008237 | Hypothalamic hypothyroidism | 4 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0012559 | Increased T3/T4 ratio | 4 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0011779 | Anaplastic thyroid carcinoma | 4 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0002895 | Papillary thyroid carcinoma | 4 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0100030 | Accessory ectopic thyroid tissue | 4 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0031507 | Decreased circulating T4 level | 4 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0100647 | Graves disease | 4 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0012560 | Decreased T3/T4 ratio | 4 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0011774 | Thyroid follicular adenoma | 4 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0040198 | Non-medullary thyroid carcinoma | 4 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0011788 | Increased circulating free T3 | 4 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0000866 | Euthyroid multinodular goiter | 4 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0011778 | Thyroid atypical adenoma | 4 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0008245 | Pituitary hypothyroidism | 4 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0011777 | Thyroid papillary adenoma | 4 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0002865 | Medullary thyroid carcinoma | 4 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0032210 | Decreased circulating free T3 | 4 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0033077 | Increased circulating free T4 level | 4 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0011773 | Uninodular goiter | 4 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0006781 | Hurthle cell thyroid adenoma | 4 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0008237 | Hypothalamic hypothyroidism | 4 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0006731 | Follicular thyroid carcinoma | 4 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0033078 | Decreased circulating free T4 level | 4 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0005987 | Multinodular goiter | 4 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0100029 | Lingual thyroid | 4 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0031506 | Increased circulating T4 level | 4 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0100030 | Accessory ectopic thyroid tissue | 4 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0031507 | Decreased circulating T4 level | 4 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0100647 | Graves disease | 4 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0012559 | Increased T3/T4 ratio | 4 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0011779 | Anaplastic thyroid carcinoma | 4 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0002895 | Papillary thyroid carcinoma | 4 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0000866 | Euthyroid multinodular goiter | 4 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0012560 | Decreased T3/T4 ratio | 4 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0011774 | Thyroid follicular adenoma | 4 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0040198 | Non-medullary thyroid carcinoma | 4 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0011788 | Increased circulating free T3 | 4 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0033077 | Increased circulating free T4 level | 4 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0011773 | Uninodular goiter | 4 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0011778 | Thyroid atypical adenoma | 4 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0008245 | Pituitary hypothyroidism | 4 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0011777 | Thyroid papillary adenoma | 4 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0002865 | Medullary thyroid carcinoma | 4 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0032210 | Decreased circulating free T3 | 4 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0033078 | Decreased circulating free T4 level | 4 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0005987 | Multinodular goiter | 4 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0100029 | Lingual thyroid | 4 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0031506 | Increased circulating T4 level | 4 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0006781 | Hurthle cell thyroid adenoma | 4 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0008237 | Hypothalamic hypothyroidism | 4 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0006731 | Follicular thyroid carcinoma | 4 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0011779 | Anaplastic thyroid carcinoma | 4 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0002895 | Papillary thyroid carcinoma | 4 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0100030 | Accessory ectopic thyroid tissue | 4 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0031507 | Decreased circulating T4 level | 4 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0100647 | Graves disease | 4 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0012559 | Increased T3/T4 ratio | 4 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0040198 | Non-medullary thyroid carcinoma | 4 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0011788 | Increased circulating free T3 | 4 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0000866 | Euthyroid multinodular goiter | 4 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0012560 | Decreased T3/T4 ratio | 4 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0011774 | Thyroid follicular adenoma | 4 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0002865 | Medullary thyroid carcinoma | 4 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0032210 | Decreased circulating free T3 | 4 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0033077 | Increased circulating free T4 level | 4 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0011773 | Uninodular goiter | 4 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0011778 | Thyroid atypical adenoma | 4 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0008245 | Pituitary hypothyroidism | 4 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0011777 | Thyroid papillary adenoma | 4 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0006731 | Follicular thyroid carcinoma | 4 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0033078 | Decreased circulating free T4 level | 4 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0005987 | Multinodular goiter | 4 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0100029 | Lingual thyroid | 4 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0031506 | Increased circulating T4 level | 4 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0006781 | Hurthle cell thyroid adenoma | 4 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0008237 | Hypothalamic hypothyroidism | 4 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0040198 | Non-medullary thyroid carcinoma | 4 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0011788 | Increased circulating free T3 | 4 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0000866 | Euthyroid multinodular goiter | 4 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0012560 | Decreased T3/T4 ratio | 4 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0011774 | Thyroid follicular adenoma | 4 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0002865 | Medullary thyroid carcinoma | 4 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0032210 | Decreased circulating free T3 | 4 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0033077 | Increased circulating free T4 level | 4 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0011773 | Uninodular goiter | 4 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0011778 | Thyroid atypical adenoma | 4 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0008245 | Pituitary hypothyroidism | 4 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0011777 | Thyroid papillary adenoma | 4 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0006731 | Follicular thyroid carcinoma | 4 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0033078 | Decreased circulating free T4 level | 4 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0005987 | Multinodular goiter | 4 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0100029 | Lingual thyroid | 4 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0031506 | Increased circulating T4 level | 4 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0006781 | Hurthle cell thyroid adenoma | 4 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0008237 | Hypothalamic hypothyroidism | 4 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0002895 | Papillary thyroid carcinoma | 4 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0100030 | Accessory ectopic thyroid tissue | 4 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0031507 | Decreased circulating T4 level | 4 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0100647 | Graves disease | 4 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0012559 | Increased T3/T4 ratio | 4 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0011779 | Anaplastic thyroid carcinoma | 4 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0011779 | Anaplastic thyroid carcinoma | 4 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0002895 | Papillary thyroid carcinoma | 4 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0100030 | Accessory ectopic thyroid tissue | 4 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0031507 | Decreased circulating T4 level | 4 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0100647 | Graves disease | 4 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0012559 | Increased T3/T4 ratio | 4 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0040198 | Non-medullary thyroid carcinoma | 4 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0011788 | Increased circulating free T3 | 4 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0000866 | Euthyroid multinodular goiter | 4 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0012560 | Decreased T3/T4 ratio | 4 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0011774 | Thyroid follicular adenoma | 4 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0008245 | Pituitary hypothyroidism | 4 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0011777 | Thyroid papillary adenoma | 4 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0002865 | Medullary thyroid carcinoma | 4 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0032210 | Decreased circulating free T3 | 4 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0033077 | Increased circulating free T4 level | 4 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0011773 | Uninodular goiter | 4 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0011778 | Thyroid atypical adenoma | 4 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0008237 | Hypothalamic hypothyroidism | 4 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0006731 | Follicular thyroid carcinoma | 4 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0033078 | Decreased circulating free T4 level | 4 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0005987 | Multinodular goiter | 4 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0100029 | Lingual thyroid | 4 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0031506 | Increased circulating T4 level | 4 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0006781 | Hurthle cell thyroid adenoma | 4 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0011775 | Thyroid macrofollicular adenoma | 5 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0011776 | Thyroid microfollicular adenoma | 5 | BCL10 CL E G H | 8915 | 52417 | | | | ORPHA | 0 | | 116 | 989 | 603517 |
HP:0000820 | HP:0011775 | Thyroid macrofollicular adenoma | 5 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0011776 | Thyroid microfollicular adenoma | 5 | BIRC3 CL E G H | 330 | 52417 | | | | ORPHA | 0 | | 51 | 591 | 601721 |
HP:0000820 | HP:0011775 | Thyroid macrofollicular adenoma | 5 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0011776 | Thyroid microfollicular adenoma | 5 | FOXP1 CL E G H | 27086 | 52417 | | | | ORPHA | 0 | | 700 | 3823 | 605515 |
HP:0000820 | HP:0011775 | Thyroid macrofollicular adenoma | 5 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0011776 | Thyroid microfollicular adenoma | 5 | IGH CL E G H | 3492 | 52417 | | | | ORPHA | 0 | | 179 | 5477 | 146910 |
HP:0000820 | HP:0011775 | Thyroid macrofollicular adenoma | 5 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0011776 | Thyroid microfollicular adenoma | 5 | MALT1 CL E G H | 10892 | 52417 | | | | ORPHA | 0 | | 422 | 6819 | 604860 |
HP:0000820 | HP:0011776 | Thyroid microfollicular adenoma | 5 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0011775 | Thyroid macrofollicular adenoma | 5 | TWNK CL E G H | 56652 | 609286 | Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3 | 609286 | C1836439 | OMIM | 0 | | 450 | 1160 | 606075 |
HP:0000820 | HP:0011775 | Thyroid macrofollicular adenoma | 5 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |
HP:0000820 | HP:0011776 | Thyroid microfollicular adenoma | 5 | VPS13A CL E G H | 23230 | 2388 | | | | ORPHA | 0 | | 2362 | 1908 | 605978 |